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Inbred strain 2 guinea pigs were vaccinated with Mycobacterium bovis BCG or were left unvaccinated. They
were maintained for 6 weeks on defined, isocaloric diets containing either 30% (control animals) or 10%
(animals receiving low protein) ovalbumin as the sole protein source. Animals were challenged by the
respiratory route with a low dose of virulent M. tuberculosis H37Rv and killed 4 weeks later. Protein-
malnourished animals were not protected by previous vaccination with BCG. Lymphocytes isolated from
various tissues were tested in vitro for proliferative responses to mitogen (concanavalin A) and antigen (purified
protein derivative [PPD]), production of interleukin-2 (IL-2), and response to exogenous recombinant IL-2
(rIL-2). Protein-malnourished guinea pigs responded only weakly to PPD skin tests, and their blood and lymph
node lymphocytes exhibited impaired proliferation when cultured with PPD in vitro. IL-2 levels were
consistently low in cultures of stimulated blood and spleen lymphocytes from protein-deprived animals. BCG
vaccination of nutritionally normal guinea pigs, on the other hand, induced significantly more IL-2 production
by PPD- and concanavalin A-stimulated lymphocytes. The addition of exogenous mouse rIL-2 (40 and 80 U/ml)
in vitro to PPD-stimulated blood and lymph node cells from nonvaccinated, protein-deprived guinea pigs
resulted in no improvement of the proliferative response. Previous vaccination of malnourished guinea pigs did
not consistently enhance the response of PPD-stimulated lymphocytes to added rIL-2. Dietary protein
deficiency and BCG vaccination appear to modulate antigen-driven cellular immunity in animals with
tuberculosis by altering the production of, and the response to, IL-2 by PPD-stimulated lymphocytes.
Dietary deficiencies of specific nutrients are consistently
associated with profound impairment of cell-mediated immu-
nity in both humans and experimental animals (1, 13).
Malfunctions ofT lymphocytes in nutrient-deprived subjects
include the inability to mount a delayed hypersensitivity skin
test and failure to proliferate in vitro when stimulated with
mitogens or antigens (16). Recently, nutrient deprivation has
been associated with alterations in the levels of lymphokines
and monokines, including interleukin-1 and interleukin-2
(IL-2), which are produced by the cells of malnourished
subjects (12, 24).
IL-2 is a lymphocytotropic hormone that is produced by
helper-inducer T lymphocytes and that plays a central role in
the generation and regulation of the immune response.
Antigen- or mitogen-induced T-cell proliferation requires the
participation of IL-2 to drive activated T lymphocytes into
cell division by means of IL-2 receptor-mediated binding
(26). Current understanding of the mechanisms of resistance
to tuberculosis and other mycobacterial infections attributes
a crucial role to IL-2 (7). Deficiencies in the synthesis of
and/or response to IL-2 have been implicated in the impaired
cell-mediated immune reactions observed in some animals
with mycobacterial infections. Under certain experimental
conditions, mice infected with Mycobacterium bovis BCG
exhibit reduced tuberculin (purified protein derivative
[PPD]) hypersensitivity and depressed PPD-induced lym-
phoproliferation associated with a reduction in IL-2 produc-
tion in vitro by stimulated cells (3, 4, 30). Mice infected with
Mycobacterium lepraemurium were found to have a similar
IL-2 defect when their splenocytes were cultured with a
T-cell mitogen, concanavalin A (ConA) (10, 11). In patients
with leprosy or tuberculosis, impaired cellular responses to
* Corresponding author.
mycobacterial antigens in vitro have been accompanied by
significant decreases in IL-2 production and defective IL-2
receptor expression (9, 22, 25, 28). In some of these studies,
the addition of exogenous IL-2 to lymphocyte cultures
reversed the T-cell unresponsiveness (3, 9, 25), while other
investigators reported no beneficial influence of added IL-2
in vitro (11, 22, 28).
In earlier studies with a guinea pig model of respiratory
tuberculosis, we have demonstrated that chronic, moderate
protein deficiency severely impairs PPD-induced T-lympho-
cyte functions in vivo and in vitro (18, 20) and profoundly
compromises the ability of the BCG vaccine to protect
animals against pulmonary infection with virulent Mycobac-
terium tuberculosis (2, 17). These diet-induced defects were
rapidly reversed following transfer to an adequate diet,
suggesting that malnourished guinea pigs fail to expand
clones of antigen-sensitized T lymphocytes (19). Recently,
we documented increased levels of T cells bearing receptors
for the Fc portion of immunoglobulin G (Ty) in the periph-
eral blood of protein-deprived guinea pigs (D. N. McMurray,
R. A. Bartow, and C. L.Mintzer, submitted for publication).
These Ty cells have been assigned a suppressor role in some
patients with tuberculosis (14).
In this study, we tested the hypothesis that vaccination
with BCG augments cellular immunity and antimycobacte-
rial resistance by stimulating enhanced IL-2 activity, while
protein malnutrition depresses T-cell immunity and disease
resistance in animals with experimental tuberculosis by
impairing the synthesis of and/or response to IL-2 by lym-
phocytes in vitro.
(Data from this study were presented, in part, in a previ-
ous report [R. L. Parr and D. N. McMurray, Fed. Am. Soc.
Exp. Biol. J. 2:436, 1988].)
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MATERIALS AND METHODS
Experimental animals. Male and female inbred strain 2
guinea pigs (weight, 150 to 250 g) were obtained from a
commercial supplier (Veterinary Resources Division, Uni-
versity of Texas System Science Park, Bastrop, Tex.). The
animals were housed individually in polycarbonate cages
with stainless steel grid floors and feeders, and they were
given food and tap water ad libitum. Each animal was
randomly assigned to a vaccination and diet treatment. Body
weights were recorded weekly during the experiment.
Experimental diets. The purified experimental diets were
obtained commercially (Dyets, Inc., Bethlehem, Pa.) and
were prepared in the formulation we have described previ-
ously (21). The control diet was designed to meet the
recommended nutritional requirements for guinea pigs (23)
and contained 30% ovalbumin as the sole protein source.
The low protein (LP) diet was isocaloric and identical to the
control diet in every nutrient except protein (10% ovalbu-
min). Before initiation of the experimental diets, animals
were weaned from commercial chow by feeding them a
mixture of ground chow and the powdered control diet,
which varied gradually from 50% commercial chow to no
commercial chow over a 2-week period. Thereafter, guinea
pigs were given their assigned powdered diet, with fresh
food provided daily.
BCG vaccination. Guinea pigs in vaccination groups re-
ceived a subcutaneous injection of 0.2 ml of M. bovis BCG
(Copenhagen 1331; Statens Seruminstitut, Copenhagen,
Denmark) in the left inguinal region 6 weeks prior to pulmo-
nary challenge. The lyophilized BCG vaccine was reconsti-
tuted with sterile physiological saline to deliver approxi-
mately 103 viable organisms per animal.
Respiratory infection. M. tuberculosis H37Rv (ATCC
27294) was obtained from the American Type Culture Col-
lection (Rockville, Md.) and was stored as single-cell sus-
pensions at -70°C (8). Six weeks following initiation of the
experimental diets, all guinea pigs were infected via the
respiratory route by using an aerosol chamber as described
previously (31). The infecting inoculum of virulent M. tuber-
culosis H37Rv introduced into the nebulizer was adjusted
empirically to result in the inhalation and retention of
approximately 10 viable organisms per animal. The infection
was performed in a biohazard facility designed for use with
class 3 human microbial pathogens. Exposure of groups of
guinea pigs, which were selected randomly from those on the
diet treatments, resulted in a uniform, reproducible infection
of all animals with mycobacteria.
PPD skin tests. All animals were shaved on the right side
and injected intradermally with 0.1 ml of PPD (PPD-RT23;
Statens Seruminstitut) containing 100 tuberculin units.
These injections were done 24 h before sacrifice, and two
perpendicular diameters of induration were measured just
prior to sacrifice.
Necropsy procedure. Guinea pigs were killed by the intra-
peritoneal injection of 1 to 3 ml of sodium pentobarbital (Fort
Dodge Laboratories, Inc., Fort Dodge, Iowa) 4 weeks fol-
lowing respiratory infection. A blood sample was obtained
immediately via cardiac puncture by using a 10-ml heparin-
ized syringe. Recovery of viable M. tuberculosis was accom-
plished by aseptically removing the right lower lung lobe and
half of the spleen and homogenizing each tissue in sterile
saline with an homogenizer (Potter-Elvejem). Homogenates
were diluted 10-fold in sterile saline and streaked in duplicate
onto agar plates (Middlebrook 7H10). After 2 to 3 weeks of
incubation at 37°C, the number of colonies was counted and
expressed as the mean log1o viable M. tuberculosis H37Rv
organisms per tissue.
Lymphocyte blastogenesis. Antigen-induced lymphoprolif-
eration was assessed in vitro by an established procedure
(2). The bronchotracheal lymph nodes and the other half of
the spleen were removed aseptically, and a single-cell sus-
pension was prepared by gently homogenizing each tissue in
a separate sterile homogenizer (Ten Broeck) in tissue culture
medium (RPMI 1640). Lymphocytes from peripheral blood
were separated by density gradient centrifugation on lym-
phocyte separation medium (Organon Teknika Corp., Dur-
ham, N.C.). Lymphocytes at the interface were removed
and washed three times in phosphate-buffered saline with 2%
fetal bovine serum. The viability of spleen, lymph node, and
blood lymphocytes was determined by trypan blue exclusion
and counting in a hemacytometer. After the viability was
determined, the cells were suspended in RPMI 1640 medium
(Irvine Scientific, Santa Ana, Calif.) containing 10% fetal
bovine serum, penicillin (100 U/ml), streptomycin (100 ,ug/
ml), 2-mercaptoethanol (10 ,uM), and L-glutamine (2 ,uM) and
placed into wells (2 x 105 cells per well) of microdilution
plates (Corning Glass Works, Coming, N.Y.). Triplicate
cultures were stimulated with PPD (Statens Seruminstitut) at
final concentrations of 25 and 12.5 ,ug/ml and with ConA
(Sigma Chemical Co., St. Louis, Mo.) at a final concentra-
tion of 20 p.g/ml. Identical sets of blood and lymph node
cultures received either 40 or 80 U of mouse recombinant
IL-2 (rIL-2; Genzyme, Boston, Mass.) per ml. These con-
centrations of rIL-2 were selected based on preliminary
dose-response experiments in normal guinea pig lympho-
cytes and the range of IL-2 activities normally expressed in
ConA-stimulated lymphocytes from control animals (20 to 40
IU/ml). Splenocytes were not used for these experiments
because they routinely do not respond to PPD in vitro as well
as the other cell populations do. Control cultures received
cells and medium alone, with and without added rIL-2. The
cells were then incubated for 4 days at 37°C in a 5% CO2
atmosphere. On the final day of incubation, each well was
labeled for 6 h with 0.8 ,uCi of tritiated thymidine (6.7
Ci/mmol; Dupont, NEN Research Products, Boston,
Mass.). The cultures were then harvested onto fiber glass
filter disks and counted in a liquid scintillation counter
(LS8000; Beckman Instruments, Inc., Fullerton, Calif.). The
data are expressed as a stimulation index, defined as a ratio
of mean counts per minute in stimulated cultures to that of
unstimulated cultures of the same cells.
IL-2 assay. Supernatants were harvested from the PPD-
and ConA-stimulated blood and spleen lymphocyte cultures
described above by using a sample harvester (Mash II; M. A.
Bioproducts, Walkersville, Md.) and were quantitatively
assayed for IL-2 by the procedure of Gillis et al. (5) as
modified by Lafferty et al. (15). Supernatants from triplicate
wells were pooled and filter sterilized prior to the assay.
Serial twofold dilutions of each test supernatant were made
in triplicate in a 96-well culture plate. An IL-2-dependent cell
line, CTLL-2 (American Type Culture Collection), was used
to quantify the amount of IL-2 in each dilution (6). A fraction
of the CTLL-2 cells (5 x 104/ml) was added to an equal
volume of diluted supernatant in each well, and the cultures
were incubated in a 5% CO2 atmosphere at 37°C for 20 h.
The cultures were then pulsed with 1 ,uCi of tritiated
thymidine per well for 6 h. Uptake of the radiolabel by the
CTLL-2 cells was measured by counting the radioactivity of
the harvested cells in a liquid scintillation counter as de-
scribed above.
A standard IL-2 concentrate was assayed along with each
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TABLE 1. Effect of diet and BCG vaccination on growth, tuberculin hypersensitivity, and infection level in guinea pigs
4 weeks after challenge with virulent M. tuberculosis
Vaccination Diet" Change in PPD skin test Log1o no. of viable mycobacteria in:body wt (g)b (mm)' Lung Spleen
BCG LP -10 8d 7.9 ± 2.ld 6.80 ± 0.14d 4.13 ± 0.24
C +100 ± 18e 14.2 ± 1.5e 5.56 ± 0.13e 2.74 ± 0.34e
None LP -28 ± 12d 5.1 ± 1.8d 6.86 ± 0.16d 4.33 ± 0.19d
C +76 ± 30e 16.6 ± 1.3e 6.94 ± 0.06d 3.72 ± 0.35d
aLP, Low protein diet (10% ovalbumin); C, control diet (30% ovalbumin).
b Values are means ± standard errors of the mean of four to five animals per treatment for all variables. Net change in body weight was calculated over the
entire length of the experiment (9 to 10 weeks).
' Diameter of induration was measured 24 h after intradermal injection of 100 U of PPD.d.e Means denoted by the same superscript in each column were not significantly different (P > 0.05).
set of supernatants from guinea pig lymphocyte cultures.
The supernatant harvested from ConA-stimulated mouse
splenocytes was concentrated by ammonium sulfate precip-
itation, dialysis, and filter sterilization. This concentrate
provided data for a dose-response curve to set a standard
50% maximal response by plotting the stimulation index
against the dilutions (5). The concentration of IL-2 in the
reference supernatant was set arbitrarily at 100 U/ml, and
the IL-2 activity of the test supernatant was calculated as
follows: IL-2 (units per milliliter) = [(dilution of 50% maxi-
mum counts per minute of the test supernatant)/(dilution of
50% maximum counts per minute of the reference superna-
tant)] x 100.
Statistical analysis. The analysis of variance was used to
test the effects of the independent variables (diet and vacci-
nation) on the dependent variables measured. When this
analysis indicated reliable treatment effects, the significance
of differences between means was assessed by the Duncan
new multiple range test (27). A 95% confidence level was set
for all tests.
RESULTS
Influence of diet and BCG vaccine on growth, tuberculin
hypersensitivity, and acquired resistance. Chronic, moderate
dietary protein deficiency (LP diet) resulted in gradual
weight loss in both BCG-vaccinated and nonvaccinated
guinea pigs over the 10 weeks of the experiment (Table 1). In
contrast, animals fed the control diet grew steadily. Vacci-
nation with BCG did not affect weight change significantly in
guinea pigs in either diet group.
Table 1 also contains the results of delayed hypersensitiv-
ity skin tests with PPD. The data represent the mean
diameter of induration measured 24 h following the intrader-
mal injection of 100 tuberculin units. Tuberculin reactions
were markedly smaller in protein-malnourished guinea pigs,
regardless of their previous vaccination with BCG. Control
animals mounted strong dermal responses to PPD. The
vaccine effect was not statistically significant, perhaps be-
cause by 4 weeks postchallenge with M. tuberculosis the
hypersensitivity expressed was influenced predominantly by
the virulent infection.
BCG vaccine-induced resistance was expressed as a sig-
nificant reduction in the number of viable mycobacteria
recovered from the right lower lung lobes and the spleens of
control guinea pigs (Table 1). Well-nourished, vaccinated
animals harbored 10- to 60-fold fewer M. tuberculosis iso-
lates than did nonvaccinated animals that consumed the
same (control) diet. In contrast, previous vaccination with
BCG did not confer protection on protein-deprived (LP diet)
guinea pigs, and there was no significant difference in the
level of infection between vaccinated and nonvaccinated
animals maintained on the LP diet. However, protein defi-
ciency did not exacerbate the infection beyond that observed
in the nonvaccinated controls.
Production of functional IL-2 in vitro. Table 2 documents
the significant effect exerted by both protein deficiency and
BCG vaccination on the amount of functional IL-2 released
into the supernatant of cirulating and splenic lymphocytes
stimulated in vitro with either a polyclonal activator (ConA)
or a specific antigen (PPD). The cells were taken from guinea
pigs 4 weeks postchallenge with virulent M. tuberculosis by
the respiratory route. Peripheral blood lymphocytes from
malnourished animals, regardless of vaccination status, pro-
duced essentially no detectable IL-2 when stimulated with
PPD, while splenocytes from the same animals were equally
unable to make IL-2 in response to ConA. BCG vaccination
of well-nourished animals, on the other hand, resulted in a
dramatic enhancement in IL-2 production by both lympho-
cyte populations. Splenocytes from vaccinated guinea pigs
maintained on the control diet produced nearly 10-fold more
IL-2 in response to PPD or ConA than did splenocytes from
their nonvaccinated counterparts. Peripheral blood lympho-
cytes from BCG-vaccinated animals also produced more
IL-2 in response to both stimuli in vitro, but the increase was
statistically significant only for ConA.
Effect of exogenous rIL-2 on proliferation in vitro. Figure 1
illustrates the impact of protein deficiency on the prolifera-
TABLE 2. IL-2 activity in vitro responds to diet and BCG
vaccination in the mitogen- and antigen-stimulated culture
supernatants of lymphocytes from guinea pigs
infected with virulent M. tuberculosis
IL-2 concn (U/ml)b
Treat- Group" Blood Spleen
ment
ConA PPD ConA PPD
Diet LP 20 ± 15' 0' 0' 18 ± 6c
C 50 22c 29 13d 13 10d 14± 8-
BCG Vaccinated 110 ± 27d 68 ± 35d 152 ± 26e 93 ± 23d
Nonvacci- 43 + 20c 30 ± 15d 18 10d 8 6c
nated
'LP, Low protein diet (10% ovalbumin); C, control diet (30% ovalbumin).
b Bioassay using the proliferation of an IL-2-dependent CTLL-2 cell line
(6); values are means + standard errors of the mean of four to five animals per
treatment.
c.d.e Means denoted by the same superscript in each column were not
significantly different (P > 0.05).
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FIG. 1. Lymphocytes from nonvaccinated guinea pigs infected with virulent M. tuberculosis; influence of diet on lymphoproliferative
responses to PPD, and the effect of exogenous rIL-2 in vitro; values are means ± standard errors of the mean of four to five animals per
treatment; the stimulation index is the ratio of counts per minute in PPD-stimulated cultures over that in unstimulated cells from the same
tissue; the asterisks indicate a significant difference (P < 0.05) because of diet at the same dose of exogenous rIL-2.
tive responses of blood and lymph node lymphocytes from
nonvaccinated guinea pigs that were challenged 4 weeks
earlier with virulent M. tuberculosis. The lymphocytes were
cultured with PPD alone or with PPD and either 40 or 80 U
of exogenous rIL-2 per ml. Background uptake of tritiated
thymidine in unstimulated cultures was unaffected by diet or
the addition of rIL-2. The overall response of blood lympho-
cytes was 8 to 10 times greater than that of lymph node cells
(note the scale differences on the vertical axis in Fig. 1). The
addition of exogenous rIL-2 did not result in a significant
alteration of antigen-induced proliferation in either cell pop-
ulation from guinea pigs in either diet treatment group,
although lymph node cells from animals in both diet groups
responded in a dose-dependent fashion to exogenous rIL-2
by increasing their proliferation in the presence of PPD.
A similar study performed on lymphocytes taken from
BCG-vaccinated guinea pigs revealed the data presented in
Fig. 2. Differences because of diet were more dramatic than
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those seen in cells from nonvaccinated animals. Protein
deficiency profoundly suppressed the PPD-induced prolifer-
ation of both lymph node and blood lymphocytes compared
with that of similar cells taken from control guinea pigs. As
was observed in nonvaccinated animals (Fig. 1), peripheral
blood lymphocytes from protein-deprived guinea pigs re-
sponded less effectively when rIL-2 was added to the cul-
tures. However, none of the changes observed with added
rIL-2 were statistically significant.
DISCUSSION
We demonstrated a defect in mitogen- and antigen (PPD)-
stimulated IL-2 production by lymphocytes from chronically
protein-malnourished guinea pigs following respiratory chal-
lenge with virulent M. tuberculosis. Peripheral blood and
splenic lymphocytes from protein-deprived animals pro-
duced essentially undetectable levels of functional IL-2
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FIG. 2. Lymphocytes from BCG-vaccinated guinea pigs infected with virulent M. tuberculosis; impact of diet on lymphoproliferative
responses to PPD, and the effect of added rIL-2 in vitro; values are means + standard errors of the mean of four to five animals per treatment;
the stimulation index is the ratio of counts per minute in PPD-stimulated cultures over that in unstimulated cells from the same tissue; the
asterisks indicate significant difference (P < 0.05) because of diet at the same dose of exogenous rIL-2.
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2610 McMURRAY ET AL.
when they were cultured with optimal concentrations of
either PPD or ConA, respectively (Table 2). This defect was
accompanied by a profound impairment in the proliferative
response of lymphocytes to PPD (Fig. 2). The addition of
exogenous rIL-2 to such cultures did not reconstitute signif-
icantly the antigen-driven response of lymphocytes from
protein-deficient guinea pigs, although the lymph node cells
from nonvaccinated animals on LP and control diets re-
sponded in a dose-dependent fashion (Fig. 1). The observed
lack of proliferation in cultures of lymphocytes from animals
on the LP diet makes it highly unlikely that the absence of
IL-2 in such supernatants was the result of the increased
utilization of IL-2. The failure to respond to exogenous rIL-2
may indicate that these cells were also deficient in their
expression of IL-2 receptors or that their proliferation was
being actively suppressed in vitro (29).
In the only previously published report of protein defi-
ciency and IL-2 activity (24), chronically deprived mice
demonstrated no apparent defect in IL-2 production by
ConA-stimulated splenic lymphocytes. However, IL-2-
driven alloreactive cytotoxicity was significantly reduced in
such cultures, leading the investigators to postulate an IL-2
target cell defect (24). The major difference between that
study and the present one, aside from the animal species
used, was the presence of active tuberculosis in our guinea
pigs. Future studies of the dietary effect alone in our model
should clarify this issue. In another diet study, the addition
of vitamin A to the diets of BCG-infected mice reversed the
IL-2 deficit observed in the response to PPD in vivo and in
vitro (4).
Our results are entirely consistent with a defect in IL-2
production reported in several studies involving infection
with various mycobacteria in both mice and humans. Under
certain experimental or clinical conditions, such infections
may produce the same kinds of immunologic impairment
that we observed in our malnourished guinea pigs. Thus,
infection of mice with high doses of M. bovis BCG (4, 30) or
M. lepraemurium (10, 11) was found to impair significantly
the ability of splenocytes to make IL-2 in response to
mitogenic or antigenic stimuli. Patients with either leprosy or
active tuberculosis, whose peripheral blood lymphocytes
were hyporesponsive to mycobacterial antigens in vitro,
were found to exhibit an IL-2 production defect (9, 28).
Evidence of reduced IL-2 receptor expression was also
presented (22, 28).
Attempts to reconstitute the in vitro proliferative response
by adding exogenous IL-2 have met with mixed results. In
three studies, (3, 9, 25), the addition of IL-2 to the cultures
reversed the cellular unresponsiveness, while three other
groups of investigators (11, 22, 28) reported no significant
improvement on supplementation with IL-2. In the only
study in which rIL-2 was used, the reversal of in vitro
cellular immune defects was observed in cells from patients
with tuberculosis (25). Reconstitution of T-cell-mediated
immunity was reported following the administration of an
IL-2-containing supernatant in vivo to hyporesponsive mice
infected with large doses of BCG (3). It is unlikely that our
failure to demonstrate significant enhancement of PPD-
induced proliferation of lymphocytes from guinea pigs on the
LP diet was due to inadequate IL-2 concentrations since the
doses used (40 and 80 U/ml) were two- to fourfold greater
than those previously reported to be effective in humans (25)
and were well above the levels produced by stimulated
normal guinea pig lymphocytes in vitro.
Consistent with our previous observations in this model
(2, 17, 18), protein-malnourished guinea pigs exhibited de-
fective tuberculin hypersensitivity and failure to respond to
BCG vaccination (Table 1). Differences in bacterial loads 4
to 5 weeks postchallenge correlated highly with the ultimate
outcome of tuberculosis in this model (31). Animals that
received LP diets harbored no more mycobacteria than their
nonvaccinated, well-nourished counterparts did, suggesting
that the anamnestic response to mycobacterial antigens is
more sensitive to nutritional insult than is the primary
response (2, 19).
Given the crucial role of IL-2 in driving antigen-stimulated
lymphocytes from the G1 to S phases of the cell cycle (26), it
is tempting to speculate that the relative hyporesponsiveness
of PPD-stimulated cells from protein-deprived animals is
directly related to the reduced synthesis of IL-2 in such
cultures. Direct suppression of IL-2 production in stimulated
cultures of lymphocytes from BCG-infected mice has been
observed (4, 29). The addition of exogenous IL-2 has been
reported not to reverse the suppression, although data were
not shown (29).
Successful BCG vaccination of well-nourished guinea
pigs, as evidenced by significant (10- to 60-fold) reductions in
the number of viable mycobacteria, was accompanied by
dramatic increases in the amount of IL-2 produced in vitro
(Table 2). This increase in IL-2 production was not due to an
increase in PPD-induced lymphoproliferation, since the main
effect of the vaccine for that dependent variable was not
statistically significant (compare the control responses in
Fig. 1 and 2). Thus, we conclude that BCG vaccination
primed the lymphocytes to produce IL-2 in response to
antigen in vitro (and, presumably, in vivo) in a way that was
different from the priming provided by virulent pulmonary
infection alone. Increased IL-2 production may contribute to
the success with which BCG-vaccinated guinea pigs control
their tuberculous infection, as has been reported in BCG-
infected mice (4). On the other hand, no correlation was
found between innate resistance to M. lepraemurium infec-
tion and the ability of splenocytes from various inbred
mouse strains to make IL-2 (10).
Our observations support the hypothesis that BCG vacci-
nation stimulates and that chronic protein deficiency sup-
presses T-lymphocyte functions in animals with tuberculosis
by stimulating or suppressing, respectively, IL-2 synthesis
by PPD-reactive lymphocytes. The IL-2 defect in protein-
malnourished guinea pigs was not responsive to the addition
of exogenous rIL-2, suggesting that protein deprivation may
also alter IL-2 receptor expression or function or may induce
active suppression in animals with tuberculosis of the type
seen in other mycobacterial infections (4, 29).
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